These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 22570457)

  • 1. Pediatric information in drug product labeling.
    Sachs AN; Avant D; Lee CS; Rodriguez W; Murphy MD
    JAMA; 2012 May; 307(18):1914-5. PubMed ID: 22570457
    [No Abstract]   [Full Text] [Related]  

  • 2. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012.
    Cheng CM; Shin J; Guglielmo BJ
    JAMA Intern Med; 2014 Oct; 174(10):1704-5. PubMed ID: 25127107
    [No Abstract]   [Full Text] [Related]  

  • 3. Microdosing Studies in Children: A US Regulatory Perspective.
    Roth-Cline M; Nelson RM
    Clin Pharmacol Ther; 2015 Sep; 98(3):232-3. PubMed ID: 26095312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New pediatric dosage rules: information and testing.
    Feeg VD
    Pediatr Nurs; 1998; 24(6):518, 613. PubMed ID: 10085992
    [No Abstract]   [Full Text] [Related]  

  • 5. The FDA drug approval process: focus on pediatric labeling.
    Brummel GL
    Neonatal Netw; 2001 Apr; 20(3):49-51. PubMed ID: 12144214
    [No Abstract]   [Full Text] [Related]  

  • 6. New drugs of 1998.
    Hussar DA
    J Am Pharm Assoc (Wash); 1999; 39(2):151-206; quiz 289-92. PubMed ID: 10079651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Food and Drug Administration's paternalism.
    Somberg JC
    Am J Ther; 2010; 17(6):533-4. PubMed ID: 21060255
    [No Abstract]   [Full Text] [Related]  

  • 8. Paediatric clinical trials: redressing the imbalance.
    Schreiner MS
    Nat Rev Drug Discov; 2003 Dec; 2(12):949-61. PubMed ID: 14654794
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulating the safety of pharmaceuticals: the FDA, preemption, and the public's health.
    Gostin LO
    JAMA; 2009 May; 301(19):2036-7. PubMed ID: 19454642
    [No Abstract]   [Full Text] [Related]  

  • 10. Summaries of Safety Labeling Changes Approved By FDA--Boxed Warnings Highlights July--September 2015.
    Am J Health Syst Pharm; 2015 Dec; 72(23):2008. PubMed ID: 26581924
    [No Abstract]   [Full Text] [Related]  

  • 11. Shared REMS programs expanded in 2012.
    Traynor K
    Am J Health Syst Pharm; 2013 Feb; 70(4):298, 303. PubMed ID: 23370134
    [No Abstract]   [Full Text] [Related]  

  • 12. Trends in pregnancy labeling and data quality for US-approved pharmaceuticals.
    Mazer-Amirshahi M; Samiee-Zafarghandy S; Gray G; van den Anker JN
    Am J Obstet Gynecol; 2014 Dec; 211(6):690.e1-11. PubMed ID: 24912093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where are risk evaluation and mitigation strategies headed?
    Johnson PE
    Am J Health Syst Pharm; 2010 Sep; 67(18):1511. PubMed ID: 20811027
    [No Abstract]   [Full Text] [Related]  

  • 14. DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA.
    Lesko LJ; Zineh I
    Pharmacogenomics; 2010 Apr; 11(4):507-12. PubMed ID: 20350131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US lawmakers tackle safety reforms at the FDA.
    Zwillich T
    Lancet; 2007 Jun; 369(9578):1989-90. PubMed ID: 17577942
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA labeling status of pediatric medications.
    Yoon EY; Davis MM; El-Essawi H; Cabana MD
    Clin Pediatr (Phila); 2006; 45(1):75-7. PubMed ID: 16429220
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA mulls changes to bioequivalence standards.
    Traynor K
    Am J Health Syst Pharm; 2010 Jun; 67(11):864. PubMed ID: 20484205
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving pediatric dosing through pediatric initiatives: what we have learned.
    Rodriguez W; Selen A; Avant D; Chaurasia C; Crescenzi T; Gieser G; Di Giacinto J; Huang SM; Lee P; Mathis L; Murphy D; Murphy S; Roberts R; Sachs HC; Suarez S; Tandon V; Uppoor RS
    Pediatrics; 2008 Mar; 121(3):530-9. PubMed ID: 18310202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric drug studies. Protecting pint-sized patients.
    Nordenberg T
    FDA Consum; 1999; 33(3):23-8. PubMed ID: 10443186
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in pharmacogenomic biomarker information in package inserts from the United States, the United Kingdom and Japan.
    Shimazawa R; Ikeda M
    J Clin Pharm Ther; 2013 Dec; 38(6):468-75. PubMed ID: 23895776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.